The Three Pillars of PKU Treatment at a Glance
PKU (phenylketonuria) is an inherited metabolic disorder in which the enzyme phenylalanine hydroxylase (PAH) is absent or severely reduced. Without treatment, phenylalanine (Phe) accumulates in the blood and causes irreversible brain damage. Modern PKU therapy combines three complementary approaches — the balance between them depends on genotype and severity.
Low-Phenylalanine Diet
Strict restriction of natural protein. The cornerstone since 1953. Required lifelong.
Amino Acid Formula
Supplies all essential amino acids without Phe. Taken daily, 2–4 times. Not optional.
Medical Therapy
BH4/sapropterin or pegvaliase — depending on genotype and response. Complements the diet.
Pillar 1: Low-Phenylalanine Diet
The low-phenylalanine diet is the oldest and most fundamental pillar of PKU therapy — first used by Horst Bickel in 1953 and responsible for protecting generations of people with PKU from irreversible cognitive impairment. Its principle: reduce daily phenylalanine intake sufficiently to keep blood Phe within the therapeutic range.
Because phenylalanine is present in almost all natural proteins, the PKU diet requires strict restriction of high-protein foods including meat, fish, dairy products, pulses, nuts, and ordinary grain products. Many fruits and vegetables are permitted, as are specially formulated low-phenylalanine products.
- Individual Phe tolerance varies considerably by severity — from below 200 mg Phe/day in classic PKU to over 600 mg/day in mild hyperphenylalaninaemia
- The daily Phe limit is set individually by the metabolic centre and reviewed regularly as the patient grows or their condition changes
- The diet must be maintained lifelong — the earlier recommendation to relax it after childhood is now considered scientifically obsolete and is no longer applied in clinical practice
- Elevated Phe disrupts the synthesis of neurotransmitters including dopamine and serotonin, causing measurable cognitive and psychiatric impairment in adults as well as children
- PHE Buddy automatically calculates daily phenylalanine intake — meal by meal, in real time — against the physician-set daily limit, using the BLS 4.0 database and an AI label scanner
Pillar 2: Amino Acid Formula
Because PKU patients may only consume very small amounts of natural protein, all essential amino acids must be supplied through a specialised amino acid mixture — commonly called metabolic formula. These products contain all essential amino acids without phenylalanine, making them the necessary companion to the low-Phe diet.
Formula is not an optional supplement — it is as essential as the diet itself. Without it, protein deficiency causes growth delays and cognitive developmental problems in children, and muscle loss, immune impairment, and further complications in adults.
- Frequency: 2–4 times daily, spread evenly throughout the day — this optimises amino acid absorption and maintains a consistent plasma level
- Formulations: available as powder (to mix with water), ready-to-drink liquid, or gel — depending on personal preference and tolerability
- Age-specific products: dedicated formulas exist for infants, toddlers, school-age children, adolescents, adults, and pregnant women with PKU (maternal PKU)
- Composition: most formulas also supply vitamins, minerals, and trace elements that are otherwise insufficient on a low-protein diet
- PHE Buddy formula tracking: PHE Buddy logs daily formula intake, sends reminders for each scheduled dose, and generates compliance reports for clinic appointments
Pillar 3: Medical Therapy
For a proportion of PKU patients, pharmacological treatment is available to complement — or in some cases substantially liberalise — the diet. Which medication is appropriate depends on genotype, residual PAH enzyme activity, and individual response to treatment.
Sapropterin (Kuvan®)
Sapropterin is a synthetic tetrahydrobiopterin (BH4) — the natural cofactor of the PAH enzyme. In BH4-responsive patients (approximately 20–30% of all PKU patients, predominantly milder forms with residual enzyme activity), sapropterin stabilises the remaining enzyme and increases its activity. This results in lower blood Phe levels and often a higher dietary Phe tolerance. Sapropterin is taken once daily as a tablet or dissolved powder. BH4-responsiveness is determined via a standardised 4-week loading test at a metabolic centre.
Pegvaliase (Palynziq®)
Pegvaliase is a recombinant, PEGylated phenylalanine ammonia lyase (PAL) enzyme — an enzyme substitution therapy approved for adults with classic PKU who do not respond adequately to diet and BH4. It is administered by subcutaneous injection, starting weekly and increasing in frequency over a titration phase of 6–12 months. Pegvaliase can dramatically reduce blood Phe — some patients achieve near-normal levels. Important: hypersensitivity reactions, including anaphylaxis, are possible; the therapy requires close monitoring. Approved in Germany, Austria, and Switzerland.
Blood Phe Monitoring: Recommended Frequency by Age
Regular blood Phe monitoring is the cornerstone of PKU management. Knowing your current Phe level enables timely responses — whether adjusting the diet, formula dose, or discussing options with your metabolic team. Recommended monitoring frequency depends on age and treatment status.
| Age group | Recommended frequency |
|---|---|
| 0–1 year (infants) | Weekly |
| 1–12 years (children) | Every 1–2 weeks |
| 12–18 years (adolescents) | Every 2–4 weeks |
| Adults (stable metabolic control) | Every 4–8 weeks |
| Pregnancy (maternal PKU) | Twice per week (or more often) |
- Dry blood spot cards (Guthrie cards) allow simple home testing via fingertip — no clinic visit required for the blood draw
- Many metabolic centres provide pre-addressed envelopes so home samples can be posted directly to the lab
- During therapy adjustment or poor metabolic control, even adults may need weekly monitoring
- PHE Buddy lets you record blood Phe values directly in the app and view your trend as a chart over weeks and months
Blood Phe Target Ranges per International Guidelines
Target blood Phe values are set by age group and pregnancy status. The ranges below are based on the European PKU Guidelines (van Wegberg et al., 2017) and ESKPE recommendations. Individual targets are established by the treating metabolic centre.
| Age group | Target range (blood Phe) |
|---|---|
| 0–12 years | < 360 µmol/L |
| 12–18 years | < 600 µmol/L |
| Adults | < 600 µmol/L |
| Pregnancy | 120–360 µmol/L |
Note: In maternal PKU, blood Phe should ideally be below 120 µmol/L in the first trimester to minimise the risk of foetal malformations. Pre-conception planning under close supervision from a metabolic centre is strongly recommended.
Regular Appointments at a Metabolic Centre
Alongside ongoing self-monitoring, regular appointments at a specialist metabolic centre are essential. These typically take place every 3–6 months and go beyond a simple blood test.
The multidisciplinary metabolic team
A specialist PKU team typically includes a metabolic specialist (paediatrician or internist with metabolic subspecialty training), a metabolic dietitian, and — particularly for adults and school-age children — a neuropsychologist or psychologist. Together, they review blood Phe trends, dietary logs, formula compliance, and, where indicated, neuropsychological test results. PHE Buddy's doctor portal lets you share dietary data, formula compliance, and blood value trends with the team ahead of each appointment.
- Regular lab panels: blood Phe, amino acid spectrum, albumin, ferritin, vitamin B12, vitamin D — to detect deficiencies arising from the protein-restricted diet
- Review and adjustment of the daily Phe limit based on growth, weight, and metabolic trend
- Discussion of dietary logs and formula compliance — PHE Buddy's doctor portal allows secure sharing of this data before the appointment
- Where needed: neuropsychology assessment (cognitive tests), nutritional counselling, and social support services
PHE Buddy as Your Treatment Companion: All 3 Pillars Supported
PHE Buddy was developed with patients and metabolic specialists to make the daily demands of PKU therapy as manageable as possible. The app directly supports all three pillars of treatment.
Make PKU Treatment Easier —
with PHE Buddy
Free for iOS & Android. Beta launch planned for Q3 2026 — join the waitlist now and be among the first users.
Join the Waitlist →Free · No credit card · PCM Solution GmbH, Austria